Postoperative Epileptic Seizures in Children

Luca Massimi1,2, Paolo Frassanito2, Federico Bianchi2

  • 1Neuroscience Department, Catholic University Medical School, 00168 Rome, Italy.

Insights

Postoperative seizures (PS) are less common after pediatric craniotomy than previously thought. Hyponatremia is a key risk factor for PS in children undergoing surgery for brain tumors.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Epileptology

Background:

  • Postoperative seizures (PS) affect 10-15% of patients undergoing craniotomy.
  • Limited data exists on the specific role of surgery in pediatric PS, particularly excluding confounding factors.
  • Understanding PS etiology is crucial for improving patient outcomes.

Purpose of the Study:

  • To update the understanding of the role of surgery in pediatric postoperative seizures (PS).
  • To compare seizure rates in children with intra-axial versus extra-axial supratentorial lesions.
  • To identify risk factors for PS in this specific pediatric population.

Main Methods:

  • Retrospective analysis of 165 children undergoing craniotomy for supratentorial lesions over 10 years.
  • Exclusion criteria: preoperative seizures, perioperative antiepileptic drug prophylaxis, head injury, infections, re-operation, or preoperative hyponatremia.
  • Comparison between children with intra-axial (Group 1) and extra-axial lesions (Group 2).

Main Results:

  • PS occurred in 9% and epilepsy in 3% of cases (mean follow-up: 5.7 years).
  • No significant differences in PS or epilepsy rates between intra-axial and extra-axial lesion groups.
  • Hyponatremia was a significant risk factor for PS in the extra-axial lesion group (p=0.02).

Conclusions:

  • Pediatric neurosurgery for supratentorial lesions has a lower rate of PS and epilepsy when excluding specific confounding factors.
  • Hyponatremia is a significant predictor of PS in children with extra-axial lesions.
  • While neurosurgery is generally safe, surgical complications can contribute to late-onset epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
246
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
541
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
806
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
538
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
248
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
555